Form 4: Arteris Director Wayne C. Cantwell Sells 15,000 Shares Under 10b5-1 Trading Plan

Director Wayne C. Cantwell sold 15,000 shares of Arteris, Inc. common stock on September 6, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Wayne C. Cantwell, a director of Arteris, Inc., sold 15,000 shares of common stock on September 6, 2024.
• The sale was executed under a 10b5-1 trading plan adopted on June 7, 2024.
• The shares were sold at a weighted average price of $6.9467, with individual prices ranging from $6.73 to $7.28.
• Following the transaction, Cantwell directly owns 243,198 shares of Arteris, Inc. common stock.
• Cantwell also indirectly owns 38,761 shares through the Decathlon Capital Management 401K Plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The use of a 10b5-1 plan suggests the sale was pre-planned and doesn't necessarily reflect a negative outlook on the company.

Industry Context

Sales by company insiders are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan suggests the insider is selling shares in a pre-planned manner to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, although the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates